These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 24207030)

  • 21. Efficacy and safety of degludec insulin: a meta-analysis of randomised trials.
    Monami M; Mannucci E
    Curr Med Res Opin; 2013 Apr; 29(4):339-42. PubMed ID: 23368895
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Degludec: a novel basal insulin.
    Kalra S; Baruah MP; Niazi AK
    Recent Pat Endocr Metab Immune Drug Discov; 2012 Jan; 6(1):18-23. PubMed ID: 22280221
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The importance of postprandial glycemic control: optimizing add-on therapy to basal insulin.
    Shaefer CF; Anderson J
    Postgrad Med; 2016 Jan; 128(1):137-44. PubMed ID: 26548422
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Basal insulins: Pharmacological properties and patient perspectives.
    Abrahamson MJ
    Prim Care Diabetes; 2010 Apr; 4 Suppl 1():S19-23. PubMed ID: 20394887
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insulin degludec: a novel basal insulin analogue.
    Goldman-Levine JD; Patel DK; Schnee DM
    Ann Pharmacother; 2013 Feb; 47(2):269-77. PubMed ID: 23386075
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insulin degludec allows for better glycaemic control with a lower risk of hypoglycaemia in patients with chronic kidney disease and type 2 diabetes.
    Dolores García de Lucas M; Avilés Bueno B; Rivas Ruiz F; Olalla Sierra J
    Diabetes Res Clin Pract; 2020 Apr; 162():108094. PubMed ID: 32113852
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of new basal insulin analogues in the initiation and optimisation of insulin therapy in type 2 diabetes.
    Baxter MA
    Acta Diabetol; 2008 Dec; 45(4):253-68. PubMed ID: 18766296
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Diabetes mellitus type 1 and 2. Flexible therapy with insulin degludec].
    Rausch R
    Med Monatsschr Pharm; 2014 Jul; 37(7):273-4. PubMed ID: 25065174
    [No Abstract]   [Full Text] [Related]  

  • 29. An update on the long-acting insulin analogue glargine.
    Thisted H; Johnsen SP; Rungby J
    Basic Clin Pharmacol Toxicol; 2006 Jul; 99(1):1-11. PubMed ID: 16867163
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insulin analogues and severe hypoglycaemia in type 1 diabetes.
    Kristensen PL; Hansen LS; Jespersen MJ; Pedersen-Bjergaard U; Beck-Nielsen H; Christiansen JS; Nørgaard K; Perrild H; Parving HH; Thorsteinsson B; Tarnow L
    Diabetes Res Clin Pract; 2012 Apr; 96(1):17-